Back to homepageTo support your biomanufacturing processes and productions aimed at developing molecules or cellular products of interest to humans, animals or the environment, Smaltis and its experts are at your side at every step, from the selection of production tools to the control of manufactured products.
Who are you?
What are you looking for?
In the context of your bioproduction projects, you are seeking customized in vitro solutions in microbiology and molecular biology to optimize your manufacturing tools and control your products. Smaltis laboratory is your preferred service provider to meet your needs, thanks to its technical expertise, dedicated tools, and rigorous scientific approach.
The products you plan to develop
- Production strains
- Antibodies
- Plasmids
- Cellular products
- Recombinant proteins
The approaches you work on
Whether you are involved in the manufacturing of products for research, medical, nutritional, agri-food, or agricultural use, and/or you use strains or plasmids for your biomanufacturing projects, the skills and expertise of the Smaltis team are at your disposal to best meet your objectives.
Our offer
Antimicrobials
Let's fight infectious diseases together
Microbiota
Let's explore the health potential of microbiota together
Bioproduction
Let's build your bioproduction tools and prepare your microbial products
Genomics
Let's study the genomic and transcriptomic aspects of your projects
Strain collections
Strain collections available for your projects
At what stage are you?
| DEVELOPMENT STAGES |
1
RESEARCH AND SELECTION |
2
PRODUCTION |
3
QUALITY CONTROLS |
| OUR SERVICES |
Supply of production strains, |
Verification of strain stability, |
Control of product conformity: |
Why choose Smaltis?
Our solutions enable you to optimize, enhance, and secure your products within a rigorous scientific framework. You can entrust your projects and ideas to our experts, who will study your needs in detail and propose the appropriate solution to meet them. Choosing Smaltis means choosing to collaborate with a team specialized in genetic manipulation, working with various strains and samples, and available to discuss your developments with you.
Get in touch!
Laurence RINGENBACH
Cell Biology Lab Manager,
Immunodiagnostic Reagents,
DIACLONE SAS part of Medixbiochemica
Smaltis is a long-term partner with whom we have established a privileged relationship. We work in highly complementary domains and collaborate regularly to provide a comprehensive offering to our clients, utilizing microbiology and molecular biology services that we specifically require. We engage them for services such as sample contamination analysis, production of competent bacteria, and preparation of suspensions of inactivated strains for the development of new monoclonal antibodies. A true bond of trust has developed, facilitated by the geographical proximity of our respective locations and easy communication with their teams, whose flexibility, tenacity in problem-solving, and quality of work are crucial for us.
Caroline GEBUS
Bioprocess Scientist
OM Pharma
We use Escherichia coli strains to manufacture our Uro-Vaxom® product for the prevention of recurrent lower urinary tract infections and co-treatment of acute urinary tract infections and, in accordance with regulatory requirements, we must demonstrate the stability of our strains. We therefore asked SMALTIS to develop a tailor-made quality control method. In addition to their ability to listen to customer needs and propose new ideas, the SMALTIS team has also distinguished itself by the quality and accuracy of its analysis reports. At present, the partnership established with SMALTIS is a real asset for OM Pharma.
Agustina LLANOS
Head of Biology
ANTABIO
We have collaborated with Smaltis on several occasions since 2014, notably as part of our ANT3273 project. This is an inhaled medicine targeting a key virulence factor of Pseudomonas aeruginosa involved in pathogenesis and would be an alternative or complement to existing antibiotic therapy for the treatment of P. aeruginosa infections in chronic respiratory diseases, such as bronchiectasis. Recently, Smaltis successfully completed a MLST sequencing project of a large number of strains with a very tight timeline to study the clonality of clinical isolates of P. aeruginosa from cystic fibrosis patients. The Smaltis team stands out for its expertise, proactive approach, and its communication and adaptability, which is why we continue to trust them.
Delphine GALLAND
Head of Preclinical Clinical Studies
VETOQUINOL
For the past 10 years, we have regularly turned to Smaltis for their services and expertise in microbiology, cellular biology, and molecular biology. The entrusted work focused on evaluating the efficacy and safety of various products related to infectious diseases. The smoothness of our interactions, the responsiveness of the entire team, and their adaptation to our regulatory requirements have allowed us to advance our research projects optimally. The trust we have placed in Smaltis over these 10 years has led us to include this provider among our preferred contacts.